SCHEMBL10340544

SCHEMBL10340544

O=C(Nc1ccc(Br)cc1)c1cc2ccccc2cc1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.77
MEN1 O00255 7/20 0.77
RAB9A P51151 7/20 0.73
NPC1 O15118 6/20 0.73
POLB P06746 4/20 0.73
CASP3 P42574 1/20 0.69
SENP7 Q9BQF6 1/20 0.69
SENP6 Q9GZR1 1/20 0.69
PLG P00747 3/20 0.68
KLK1 P06870 2/20 0.68
KLK6 Q92876 2/20 0.68
MAPT P10636 3/20 0.64
MAPK1 P28482 1/20 0.64
APOBEC3A P31941 1/20 0.64
APOBEC3G Q9HC16 1/20 0.64
PLAU P00749 2/20 0.63
F2 P00734 1/20 0.63
F10 P00742 1/20 0.63
PLAT P00750 1/20 0.63
ALPL P05186 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5426499 0.92 KMT2A (0.84) KMT2AMEN1RAB9ANPC1POLB
SCHEMBL15478030 0.87 KMT2A (0.77) KMT2AMEN1RAB9ANPC1POLB
SCHEMBL57970 0.87 MEN1 (0.77) KMT2AMEN1RAB9ANPC1POLB
SCHEMBL29890853 0.87 MEN1 (0.77) KMT2AMEN1RAB9ANPC1POLB
SCHEMBL30084384 0.87 MEN1 (0.77) KMT2AMEN1RAB9ANPC1POLB
SCHEMBL10967705 0.87 MEN1 (0.64) KMT2AMEN1RAB9ANPC1POLB
SCHEMBL2129288 0.85 P2RX1 (0.71) KMT2AMEN1RAB9ANPC1POLB
SCHEMBL10597427 0.84 KMT2A (0.73) KMT2AMEN1RAB9ANPC1POLB
SCHEMBL10865627 0.84 NPC1 (0.73) KMT2AMEN1RAB9ANPC1POLB
SCHEMBL2743095 0.84 NPC1 (0.73) KMT2AMEN1RAB9ANPC1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8653086-B2 Naphthamides as anticancer agents OREGON HEALTH & SCIENCE UNIVERSITY (US) 2014-02-18 US disclosed
US-8653086-B2 Naphthamides as anticancer agents OREGON HEALTH & SCIENCE UNIVERSITY (US) 2014-02-18 US disclosed
US-7989498-B2 Immunosuppressants; autoimmune disease; organs transplantation; antiinflammatory agents; viricides; antiproliferative agents; antitumor, anticancer agents VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-08-02 US disclosed
US-7989498-B2 Immunosuppressants; autoimmune disease; organs transplantation; antiinflammatory agents; viricides; antiproliferative agents; antitumor, anticancer agents VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-08-02 US disclosed
US-7915255-B2 Metabolism-modulating agents and uses therefor VERVA PHARMACEUTICALS PTY LTD (AU) 2011-03-29 US disclosed
US-7915255-B2 Metabolism-modulating agents and uses therefor VERVA PHARMACEUTICALS PTY LTD (AU) 2011-03-29 US disclosed
EP-0190947-B1 PROCESS FOR PRODUCING AZO PIGMENTS Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo (JP) 1990-01-31 EP disclosed
US-4655844-A COUPLING AROMATIC DIAZONIUM COMPOUND WITH 3-HYDROXY-2-NAPHTHOIC ACID AND A BIS-NAPHTHYLAMETHANE KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO (JP) 1987-04-07 US disclosed
EP-0190947-A2 Process for producing azo pigments Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo (JP) 1986-08-13 EP disclosed